Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England
Yen Yi Tan(National University of Singapore), Alvina G. Lai(Health Data Research UK), Václav Papež(Hospital Universitario 12 De Octubre), Stefanie H. Mueller(Christian-Albrechts-Universität zu Kiel), Spiros Denaxas(University College London), Wai Hoong Chang(University College London)
Cited by 280
Related Papers
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
|The Lancet|2014|1.6k
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
|The Lancet Diabetes & Endocrinology|2014|1.2k
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
|Nature Communications|2020|924
Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI
|Nature Medicine|2022|499
Proteomic signatures improve risk prediction for common and rare diseases
|Nature Medicine|2024|189